ADC Therapeutics SA (ADCT) vs CAMP4 Therapeutics Corporation (CAMP)

ADC Therapeutics SA and CAMP4 Therapeutics Corporation are both Biotechnology companies. CAMP4 Therapeutics Corporation is the larger, with a market value of $216.5M against $190.2M — 1.1× the size. ADC Therapeutics SA has the higher net margin (−121.8% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, ADC Therapeutics SA leads on 10 and CAMP4 Therapeutics Corporation on 4.

Valuation

Metric ADCT CAMP Biotechnology median
P/E n/m n/m 8.42
P/S 2.90 47.40 10.01
P/B n/m n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.61 26.75 9.41
Earnings yield (44.30%) (67.25%) (31.85%)
Free cash flow yield (44.04%) (14.35%) (24.58%)

Profitability

Metric ADCT CAMP Biotechnology median
Gross margin 88.86% 100.00% 65.16%
Operating margin (125.08%) (1,254.22%) 0.00%
Net margin (121.77%) (2,543.74%) 0.00%
Free cash flow margin (127.72%) (680.36%) 0.00%
Return on equity 45.35% (545.85%) (56.36%)
Return on assets (32.25%) (148.23%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT CAMP Biotechnology median
Revenue growth (TTM) 3.03% — 6.02%
EPS growth (last fiscal year) 30.86% 76.00% 30.26%
Revenue growth, 5-year CAGR 103.35% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADCT CAMP Biotechnology median
Debt to equity (0.51) 0.00 0.00
Current ratio 3.03 4.70 4.72
Net debt to EBITDA 1.22 2.18 0.96

Dividend

Metric ADCT CAMP Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ADCT CAMP Biotechnology median
Market cap 190.23m 216.50m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack